InsidersTradesSigma
HUM Stock: price and insider trades · Australia · ASX
Track the HUM share price and the full directors' dealings record of the company, a listed equity based in Australia. Shares are quoted on AU AU, under the supervision of ASX. Operating in the Healthcare & Pharma sector, HUM has logged 4 insider filings. Market capitalisation: €242.4m. The latest transaction was filed on 14 May 2026 (Other). Among the most active insiders: Unknown. Every trade is accessible without an account.
4
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate HUM Strong Buy (bullish), based on 2 analysts. Average price target: A$0.80.
11Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 6,490 of 26,211 companies
64.2
score / 100
Value79
Quality50
FCF yld66%
Earn yld17%
EV/EBITDA13.3x
ROE4.8%
Gross mgn95%
Net mgn6.1%
Debt/EBITDA12.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 14 May 2026
Declarations4 total
ShareASXASX:2924-03090173-2A1672112
ShareASXASX:2924-03090172-2A1672111
ShareASXASX:2924-03090146-2A1672095
ShareASXASX:2924-03090145-2A1672094
4 of 4 declarations
About HUM
HUM is a company operating in the health and pharmaceutical sector, listed on the XASX market. It focuses on the development and commercialization of innovative solutions to improve patient health.
